{
  "meta": {
    "title": "Lipoproteins",
    "url": "https://brainandscalpel.vercel.app/lipoproteins-9d566196.html",
    "scrapedAt": "2025-11-29T18:23:37.025Z"
  },
  "questions": [
    {
      "id": 9052,
      "choices": [
        {
          "id": 36175,
          "text": "<p><span style=\"font-size:12.0pt;\">Familial Chylomicronemia</span></p>"
        },
        {
          "id": 36176,
          "text": "<p><span style=\"font-size:12.0pt;\">Type III Hyperlipoproteinemia</span></p>"
        },
        {
          "id": 36177,
          "text": "<p><span style=\"font-size:12.0pt;\">Abetalipoproteinemia</span></p>"
        },
        {
          "id": 36178,
          "text": "<p><span style=\"font-size:12.0pt;\">Type IIa Hyperlipoproteinemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old student has been experiencing yellowish discoloration of the palms for the past seven months, with no changes in sclera or mucous membranes and no history of chemical exposure. His lipid profile shows the below results: Laboratory investigations:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/8_IvdwEdI.jpg\" alt=\"\" width=\"398\" height=\"134\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Total cholesterol: 240 mg/dl (N = &lt; 200 mg/dl)&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">LDL cholesterol: 145 mg/dl&nbsp;(N = &lt; 100 mg/dl)&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">TG: 250 mg/dl&nbsp;(N = 60-150 mg/dl)&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">HDL cholesterol: 45 mg/dl &nbsp;(N = 40-75 mg/dl)&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Lipoprotein electrophoresis shows a broad beta band.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given these findings, what is the most likely diagnosis?</span></p>",
      "unique_key": "Q1291107",
      "question_audio": null,
      "question_video": null,
      "map_id": 30308,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Type III Hyperlipoproteinemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Type III Hyperlipoproteinemia</strong>, also known as <strong>dysbetalipoproteinemia</strong> or <strong>broad beta disease</strong>, is caused by a defect in <strong>apolipoprotein E (apoE)</strong>, which impairs the clearance of <strong>chylomicron remnants and IDL</strong> from the plasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key features include:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Elevated total cholesterol and triglycerides</strong> (typically both increased)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Broad beta band on electrophoresis</strong>, due to accumulation of remnant lipoproteins</span></li><li><span style=\"font-size:12.0pt;\"><strong>Palmar xanthomas</strong> — yellowish discoloration or deposits in the creases of the palms</span></li><li><span style=\"font-size:12.0pt;\"><strong>Increased risk of premature atherosclerosis</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient’s <strong>lipid pattern</strong>, <strong>broad beta band</strong>, and <strong>palmar discoloration</strong> (xanthomas) are classic for <strong>Type III Hyperlipoproteinemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. Familial Chylomicronemia (Type I)</strong> – Presents with <strong>very high triglycerides</strong>, <strong>creamy plasma</strong>, and <strong>eruptive xanthomas</strong>, usually without a broad beta band.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Abetalipoproteinemia</strong> – Features <strong>very low or absent apoB-containing lipoproteins</strong>, leading to <strong>low cholesterol and triglycerides</strong>, <strong>fat malabsorption</strong>, and <strong>acanthocytosis</strong>. Not seen here.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Type IIa Hyperlipoproteinemia (Familial Hypercholesterolemia)</strong> – Characterized by <strong>isolated elevated LDL</strong>, <strong>normal triglycerides</strong>, and <strong>tendon xanthomas</strong>. Not compatible with this lipid profile.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognize <strong>Type III Hyperlipoproteinemia</strong> by its unique clinical features:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Combined elevation of cholesterol and triglycerides</span></li><li><span style=\"font-size:12.0pt;\"><strong>Broad beta band</strong> on electrophoresis</span></li><li><span style=\"font-size:12.0pt;\"><strong>Palmar xanthomas</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Vasudevan 9 /ed: p245, 246.</span></p>",
      "correct_choice_id": 36176,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9063,
      "choices": [
        {
          "id": 36219,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></span></span></p>"
        },
        {
          "id": 36220,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></span></span></p>"
        },
        {
          "id": 36221,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL</span></span></span></p>"
        },
        {
          "id": 36222,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A physician is consulting a patient about his elevated triglyceride levels. The patient is non-diabetic and has no history of alcohol overuse, factors known to influence triglyceride levels. The physician explains that a certain lipoprotein is primarily responsible for transporting triglycerides synthesized by the liver. Which lipoprotein does the liver use to transport these endogenous triglycerides?</span></span></span></p>",
      "unique_key": "Q9333320",
      "question_audio": null,
      "question_video": null,
      "map_id": 30316,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) VLDL</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Very Low-Density Lipoproteins (VLDL) </strong>are produced by the <strong>liver </strong>and are responsible for <strong>transporting endogenous triacylglycerols,</strong> which are synthesized by the liver, <strong>to adipose tissue and muscle</strong>. <strong>VLDL</strong> serves as the <strong>body&#39;s internal transport </strong>mechanism for lipids it has<strong> produced or extracted from the diet and processed.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Chylomicrons</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These <strong>transport dietary, or exogenous, lipids </strong>from the <strong>intestines to other tissues </strong>in the body after a<strong> meal.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: LDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Primarily carries<strong> cholesterol to the body&#39;s cells</strong> rather than triacylglycerol.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: HDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Involved in<strong> reverse cholesterol transport,</strong> carrying <strong>cholesterol from the tissues back to the liver</strong>, and is <strong>not </strong>a primary carrier of <strong>triacylglycerol.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-110237.png\" style=\"height:490px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p 226.</span></strong></span></span></p>",
      "correct_choice_id": 36220,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9042,
      "choices": [
        {
          "id": 36135,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Facilitated diffusion&nbsp;</span></span></span></p>"
        },
        {
          "id": 36136,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pinocytosis</span></span></span></p>"
        },
        {
          "id": 36137,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phagocytosis</span></span></span></p>"
        },
        {
          "id": 36138,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Receptor-mediated endocytosis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In an experiment, a team of scientists incubates liver cells at 0&deg;C and treats them with trypsin to digest surface receptors. The temperature is then increased to 37&deg;C, and radioactive LDL is introduced to the culture. Subsequently, the labelled LDL is found inside the liver cells. What is the process responsible for the internalization of LDL called?</span></span></span></p>",
      "unique_key": "Q9055737",
      "question_audio": null,
      "question_video": null,
      "map_id": 30304,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Receptor-mediated endocytosis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> LDL</strong> is taken up by<strong> peripheral tissues</strong> in the body by<strong> receptor-mediated endocytosis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>LDL receptors </strong>are<strong> located </strong>in specialized regions called <strong>clathrin coated pits. ​​Binding of LDL to the apo-B100 receptor </strong>by <strong>apo B100</strong> &rarr; the<strong> receptor-LDL complex </strong>is internalized by <strong>endocytosis</strong> &rarr; <strong>endosome vesicle fuses</strong> with <strong>lysosomes </strong>&rarr; <strong>receptor</strong> is <strong>recycled and returns</strong> to the <strong>cell surface </strong>and <strong>LDL particle + apoproteins + cholesterol ester</strong> are <strong>hydrolyzed </strong>by <strong>lysosomal hydrolases</strong> &rarr; forms<strong> fatty acids and free cholesterol.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Facilitated diffusion:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Is the transport of<strong> low-permeability molecules</strong> with the aid of a <strong>carrier protein.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Pinocytosis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uptake of <strong>small molecules in solution</strong>, is <strong>receptor &ndash;independent.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Phagocytosis:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Process by which <strong>cells</strong> such as<strong> macrophages and neutrophils engulf large particles.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Receptor-mediated endocytosis</strong> is the <strong>specific and efficient</strong> mechanism by which <strong>LDL is internalized by liver cells,</strong> involving the interaction of<strong> LDL with cell surface LDL receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 257-258.</span></strong></span></span></p>",
      "correct_choice_id": 36138,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9057,
      "choices": [
        {
          "id": 36195,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RNA alternate splicing</span></span></span></p>"
        },
        {
          "id": 36196,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RNA editing</span></span></span></p>"
        },
        {
          "id": 36197,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DNA editing</span></span></span></p>"
        },
        {
          "id": 36198,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RNA interference</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A molecular biologist is explaining to a group of students the unique process through which Apo B48 is produced in the body. This protein is essential for the formation of chylomicrons, which transport dietary lipids from the intestines to other parts of the body. By what mechanism is Apo B48 generated?</span></span></span></p>",
      "unique_key": "Q7156971",
      "question_audio": null,
      "question_video": null,
      "map_id": 30311,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RNA editing</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apo-B-48</strong> is the major<strong> apoprotein of chylomicrons. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is synthesized only in the<strong> intestinal cells. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apo-B100 and apo-B48 </strong>are products of the <strong>same gene</strong>, but in the intestine, the <strong>mRNA </strong>undergoes <strong>editing and </strong>so produces the <strong>B48 protein. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is named so because it is only <strong>40% of the size of B100.&nbsp;&nbsp; </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-103140.png\" style=\"height:296px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: RNA alternate splicing</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This process involves the<strong> removal or inclusion </strong>of segments of the <strong>pre-mRNA transcript</strong>, leading to the production of <strong>different mRNA variants </strong>and, consequently<strong>, different proteins from the same gene. </strong>However, it is<strong> not </strong>the mechanism by which <strong>Apo B48 </strong>is produced.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: DNA editing</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DNA editing refers to<strong> direct changes to the DNA sequence itself</strong>, which is <strong>not </strong>applicable in the <strong>case of Apo B48 production</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: RNA interference</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: RNA interference is a<strong> biological process </strong>in which <strong>RNA molecules inhibit gene expression or translation by neutralizing targeted mRNA molecules. </strong>It<strong> does not </strong>involve the production of <strong>Apo B48</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Apo B48</strong> is generated through<strong> RNA editing, a post-transcriptional modification </strong>that alters the <strong>nucleotide </strong>sequence of the <strong>RNA</strong>, resulting in a <strong>shorter protein variant </strong>crucial for <strong>chylomicron formation in the intestines.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p226.</span></strong></span></span></p>",
      "correct_choice_id": 36196,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9038,
      "choices": [
        {
          "id": 36119,
          "text": "<p><span style=\"font-size:12.0pt;\">Increasing the synthesis and secretion of VLDL from liver resulting in high LDL levels in the blood</span></p>"
        },
        {
          "id": 36120,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibiting the binding of apoB to LDL receptor, thereby blocking the lipoprotein uptake and increasing the blood cholesterol levels</span></p>"
        },
        {
          "id": 36121,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreasing the availability of LDL receptors on the cell surface, resulting in decreased LDL uptake and high blood cholesterol level</span></p>"
        },
        {
          "id": 36122,
          "text": "<p><span style=\"font-size:12.0pt;\">Preventing the cholesterol breakdown into bile acids in the liver</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man with coronary artery disease (CAD) is being successfully treated with anti-atherogenic medication that targets PCSK9. Following treatment, his lipid profile normalizes, and his cardiac status improves. What is the primary function of PCSK9?</span></p>",
      "unique_key": "Q8805533",
      "question_audio": null,
      "question_video": null,
      "map_id": 30302,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Decreasing the availability of LDL receptors on the cell surface, resulting in decreased LDL uptake and high blood cholesterol level</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) normally binds to LDL receptors and promotes their degradation in lysosomes, which prevents the receptors from being recycled back to the cell surface. This natural function of PCSK9 decreases the number of LDL receptors available on cell surfaces, especially hepatocytes, resulting in reduced LDL clearance from the bloodstream and consequently higher blood cholesterol levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anti-atherogenic medications that target PCSK9 (PCSK9 inhibitors) work by inhibiting this protein, thereby preventing LDL receptor degradation. This leads to:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Increased recycling of LDL receptors back to the cell surface</span></li><li><span style=\"font-size:12.0pt;\">Greater availability of LDL receptors on hepatocytes</span></li><li><span style=\"font-size:12.0pt;\">Enhanced clearance of LDL cholesterol from the bloodstream</span></li><li><span style=\"font-size:12.0pt;\">Reduced blood LDL cholesterol levels</span></li><li><span style=\"font-size:12.0pt;\">Improved cardiovascular outcomes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>: Increasing the synthesis and secretion of VLDL - PCSK9 does not directly affect VLDL synthesis or secretion; its primary role is related to LDL receptor regulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>: Inhibiting the binding of apoB to the LDL receptor - PCSK9 does not interfere with apoB binding to LDL receptors; it affects the degradation of LDL receptors themselves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>: Preventing the breakdown of cholesterol into bile acids - PCSK9's function is not related to cholesterol metabolism into bile acids; it specifically impacts the recycling and degradation of LDL receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understanding that PCSK9 inhibitors work by preventing PCSK9-mediated degradation of LDL receptors, thereby increasing LDL receptor availability, enhancing LDL cholesterol clearance, and lowering blood cholesterol levels in patients with coronary artery disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e:&nbsp; p 271, 275, 278-279.</span></p>",
      "correct_choice_id": 36121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9033,
      "choices": [
        {
          "id": 36099,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I hyperlipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36100,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IV hyperlipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36101,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IIb hyperlipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36102,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type V hyperlipoproteinemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a clinical study examining lipid metabolism disorders, researchers observe participants with markedly elevated plasma levels of chylomicrons and triacylglycerols. Which type of hyperlipoproteinemia is most consistent with these findings?</span></span></span></p>",
      "unique_key": "Q8035906",
      "question_audio": null,
      "question_video": null,
      "map_id": 30300,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I hyperlipoproteinemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperlipoproteinemia I/Familial lipoprotein lipase deficiency (type I)&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an<strong> autosomal recessive </strong>condition presents with <strong>fasting chylomicronemia and Hypertriacylglycerolemia</strong> due to <strong>deficiency of LPL </strong>or <strong>abnormal LPL</strong> or <strong>apo C-ll deficiency</strong> causing <strong>inactive LPL.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Slow clearance of chylomicrons</strong> and <strong>VLDL</strong> with <strong>low levels of LDL</strong> and <strong>HDL are noted.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F:<strong> Eruptive xanthoma; hepatomegaly; Pain abdomen,</strong> manifests in <strong>young age </strong>with<strong> less risk</strong> of<strong> coronary disease</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>chylomicron</strong> band in <strong>fasting plasma</strong> is the<strong> </strong>characteristic finding of the disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Familial Endogenous type </strong>- due to <strong>over production of TG </strong>by liver, <strong>elevated VLDL level </strong>&rarr; <strong>Cardiac manifestations.</strong> Associated with<strong> DM, obesity and impaired glucose tolerance.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Elevation</strong> of <strong>both CHL and TG</strong> with <strong>excessive production of apo-B </strong>&rarr; <strong>elevated LDL and VLDL. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Elevated CM and VLDL. Hypertriglyceridemia </strong>secondary to disorders like <strong>obesity, excessive alcohol intake, renal failure,</strong> <strong>pancreatitis</strong>, etc. are common. Other causes:&nbsp;<strong> hepatic lipase defect, LCAT defect and Lp(a) excess and Wolman&rsquo;s disease</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type I hyperlipoproteinemia</strong>, also known as <strong>familial lipoprotein lipase deficiency, </strong>is characterized by <strong>markedly elevated plasma</strong> <strong>levels of chylomicrons </strong>due to a <strong>deficiency of lipoprotein lipase</strong> or its <strong>cofactor apolipoprotein C-II. </strong>This leads to an <strong>inability to</strong> <strong>hydrolyze </strong>the <strong>triglycerides</strong> carried by <strong>chylomicrons</strong>, resulting in <strong>high levels of both chylomicrons and triglycerides in the plasma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p245, 246.</span></strong></span></span></p>",
      "correct_choice_id": 36099,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9020,
      "choices": [
        {
          "id": 36047,
          "text": "<p><span style=\"font-size:12.0pt;\">CM &gt; LDL &gt; VLDL &gt; HDL</span></p>"
        },
        {
          "id": 36048,
          "text": "<p><span style=\"font-size:12.0pt;\">CM &gt; VLDL &gt; LDL &gt; HDL</span></p>"
        },
        {
          "id": 36049,
          "text": "<p><span style=\"font-size:12.0pt;\">HDL &gt; VLDL &gt; LDL &gt; CM</span></p>"
        },
        {
          "id": 36050,
          "text": "<p><span style=\"font-size:12.0pt;\">HDL &gt; VLDL &gt; LDL &gt; CM</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">In an electrophoretic separation procedure, a technician observes the migration of lipoproteins from the cathode (-) to the anode (+) sidewhich of the following correctly orders the lipoproteins from cathode to anode?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/4_03T9YxQ.jpg\" alt=\"\" width=\"400\" height=\"278\"></span></p>",
      "unique_key": "Q4920637",
      "question_audio": null,
      "question_video": null,
      "map_id": 30296,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;CM &gt; LDL &gt; VLDL &gt; HDL</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Plasma lipoproteins can be separated on the basis of their electrophoretic mobility:</span></p><p><span style=\"font-size:12.0pt;\">Those with higher protein content will move faster towards the anode and those with less proteins have low mobility</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Classifcation of Lipoproteins</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Depending on the density (by ultracentrifugation) or on the electrophoretic mobility, the lipoproteins in plasma are classified into five major types&nbsp;</span></p><ol><li><span style=\"font-size:12.0pt;\">Chylomicrons: Contain apoprotein B-48.</span></li><li><span style=\"font-size:12.0pt;\">Very low-density lipoproteins (VLDL) or pre-beta lipoproteins. Main apoprotein is B-100.</span></li><li><span style=\"font-size:12.0pt;\">Intermediate density lipoproteins (IDL) or broad-beta lipoproteins</span></li><li><span style=\"font-size:12.0pt;\">Low-density lipoproteins or beta lipoproteins. Major apoprotein in LDL is B-100.</span></li><li><span style=\"font-size:12.0pt;\">High-density lipoproteins or alpha lipoproteins. Major apoprotein in HDL is apo A.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Separation by Ultracentrifugation</strong></span></p><p><span style=\"font-size:12.0pt;\">The lipoproteins are characterized on the basis of their density. Fat is less dense than water; so fat floats on water. Lipoproteins with high lipid content will have a low density and so float on centrifugation. Those with high protein content will sediment easily and have a high density.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Separation by Electrophoresis</strong></span></p><p><span style=\"font-size:12.0pt;\">As a general rule, those with higher protein content will move faster towards the anode and those with fewer proteins have minimum mobility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note : pattern of electrophoresis and ultracentrifugation are different as shown in the diagram.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Electrophoresis&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Standard order from Cathode (-) to Anode (+):</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>CM &gt;LDL&gt;VLDL&gt;HDL&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ultracentrifugation: sequence is&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">CM &gt; VLDL &gt; LDL &gt; HDL</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture3_cTaOOJy.png\" width=\"2696\" height=\"2068\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Comparison of electrophoretic and ultracentrifugation patterns of lipoproteins.</span></p><p><span style=\"font-size:12.0pt;\">(VLDL: very low-density lipoproteins; IDL: intermediate density lipoproteins; LDL: low-density lipoproteins; HDL: high-density lipoproteins; FFA: free fatty acid)</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lipoprotein electrophoresis separates particles based on their <strong>protein content and charge.</strong> Understanding the typical migration pattern helps diagnose dyslipidemias and distinguish between different lipoprotein abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Lippincott 7/e: 228.</span></p>",
      "correct_choice_id": 36047,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9027,
      "choices": [
        {
          "id": 36075,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acids</span></span></span></p>"
        },
        {
          "id": 36076,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucagon</span></span></span></p>"
        },
        {
          "id": 36077,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycerol</span></span></span></p>"
        },
        {
          "id": 36078,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Three hours after a healthy middle-aged man eats a meal that includes carbohydrates, proteins, and fats, a blood sample is drawn to assess his lipid profile. Considering normal digestive physiology and the timing of the sample in relation to his meal, which component in his blood is likely to be elevated at this point?</span></span></span></p>",
      "unique_key": "Q6091017",
      "question_audio": null,
      "question_video": null,
      "map_id": 30299,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After a <strong>well-balanced meal</strong> , the <strong>products of digestion</strong> such as <strong>glucose, amino acids, triacylglycerols</strong> are packaged as <strong>chylomicrons</strong> from the<strong> intestine and VLDL</strong> from the<strong> liver enter the bloodstream </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Fatty acids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fatty acids in the <strong>blood </strong>usually <strong>increase during fasting </strong>when<strong> fat stores </strong>are mobilized for <strong>energy, </strong>not postprandially.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Glucagon</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Glucagon levels typically <strong>rise during fasting </strong>to<strong> promote glucose production</strong> and release by the <strong>liver, not</strong> after a <strong>meal </strong>when<strong> insulin is the predominant hormone.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Glycerol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Glycerol</strong> levels in the <strong>blood</strong> typically <strong>increase during triglyceride breakdown</strong>, which occurs <strong>during fasting </strong>or <strong>exercise,</strong> <strong>not postprandially.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>postprandial rise in chylomicron levels</strong> in response to a <strong>well-balanced meal</strong>, reflecting the <strong>normal physiological process </strong>of <strong>dietary fat transport.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 257-259.</span></strong></span></span></p>",
      "correct_choice_id": 36078,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9026,
      "choices": [
        {
          "id": 36071,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial type III hyperlipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36072,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abetalipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36073,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL receptor mutation</span></span></span></p>"
        },
        {
          "id": 36074,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial LPL deficiency (type l)</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old male with a familial history of increased cholesterol levels presents with an isolated elevation in LDL. His father and brother had similar lipid abnormalities. Given the isolated increase in LDL and family history, what is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q3494015",
      "question_audio": null,
      "question_video": null,
      "map_id": 30298,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL receptor mutation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipoproteinemia</strong> are categorized by <strong>Frederickson&#39;s Classification </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial hypercholesterolemia (FH) results in</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> severe <strong>hypercholesterolemia </strong>associated with<strong> premature atherosclerosis. </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>defect is in the gene</strong> for the<strong> LDL receptor or mutation </strong>in the ligand region of<strong> apo B100</strong> &rarr; so, <strong>LDL</strong> is <strong>not</strong> cleared from the<strong> </strong><strong>blood.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Familial type llI hyperlipoproteinemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> due to the <strong>abnormality</strong> in <strong>apoE</strong> , remnant <strong>clearance</strong> by the<strong> liver is defective</strong> resulting <strong>in increased levels of chylomicron and VLDL remnants.&nbsp;</strong>It can cause <strong>hypercholesterolemia, atherosclerosis, and xanthomas.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Abetalipoproteinemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Defective</strong> loading of <strong>apo B</strong> with lipid &rarr; <strong>absence of formation of chylomicrons, VLDL or LDL</strong>,<strong> low</strong> <strong>blood acylglycerols</strong> with accumulation of it in the<strong> intestine and liver.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Familial LPL deficiency (type l):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Due to deficiency </strong>of <strong>LPL or abnormal LPL or apo C-ll deficiency</strong> &rarr;&nbsp; <strong>Hypertriacylglycerolemia</strong> with slow clearance of chylomicrons and VLDL, <strong>low levels of LDL and HDL. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>LDL receptor </strong>gene mutation is characterized by <strong>isolated elevated LDL cholesterol levels </strong>and a <strong>family history of hypercholesterolemia</strong> and early <strong>cardiovascular disease.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 275,276.</span></strong></span></span></p>",
      "correct_choice_id": 36073,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9008,
      "choices": [
        {
          "id": 35999,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Chylomicronemia</span></span></span></p>"
        },
        {
          "id": 36000,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Hypercholesterolemia</span></span></span></p>"
        },
        {
          "id": 36001,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abetalipoproteinemia</span></span></span></p>"
        },
        {
          "id": 36002,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Broad Beta Disease</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the clinical presentation (as shown in image), which of the following is the most probable diagnosis? </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/1_BiC30gi.jpg\" style=\"height:190px; width:284px\" /></span></span></span></p>",
      "unique_key": "Q1136238",
      "question_audio": null,
      "question_video": null,
      "map_id": 30295,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial Hypercholesterolemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>deposition of lipids</strong> in<strong> subcutaneous tissue</strong> leads to <strong>xanthomas.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xanthelasma </strong>are<strong> lipid deposits under the periorbital skin </strong>and contain mainly <strong>cholesterol.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tendinous xanthoma </strong>are found <strong>over the tendons.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deposits of lipids </strong>in <strong>cornea</strong> lead to<strong> corneal arcus</strong>; indicating <strong>hypercholesterolemia</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Familial Chylomicronemia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F- <strong>Hepatomegaly, eruptive xanthoma and abdominal pain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Abetalipoproteinemia:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low levels of serum triglycerides,</strong> <strong>cholesterol and phospholipids</strong>. C/F-<strong> Blindness </strong>due to <strong>degenerative changes</strong> in <strong>retina</strong> and <strong>spiny projections </strong>in<strong> erythrocytes (acanthocytes).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Broad Beta Disease:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Palmar xanthoma</strong> and <strong>increased risk for vascular disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Familial Hypercholesterolemia</strong> is characterized by <strong>high LDL cholesterol levels </strong>and the presence of <strong>xanthomas</strong>, which are deposits of <strong>cholesterol in the skin and tendons</strong>, due to a<strong> genetic defect in LDL receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: P245, 246.</span></strong></span></span></p>",
      "correct_choice_id": 36000,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9022,
      "choices": [
        {
          "id": 36055,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></span></span></p>"
        },
        {
          "id": 36056,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL</span></span></span></p>"
        },
        {
          "id": 36057,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL</span></span></span></p>"
        },
        {
          "id": 36058,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 36-year-old man who consumes a fat-free, high-carbohydrate diet finds that he continues to gain weight. Considering the dietary influence on lipoprotein metabolism, which apoprotein is most likely to be elevated in his blood?</span></span></span></p>",
      "unique_key": "Q3754305",
      "question_audio": null,
      "question_video": null,
      "map_id": 30297,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Excess Carbohydrates </strong>in the <strong>body</strong> are converted to<strong> Acetyl CoA. </strong>These are then <strong>converted to Fatty acid</strong>, which <strong>gets</strong> <strong>esterified</strong> to form<strong> Endogenous TGs. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>VLDL </strong>is the<strong> carrier of endogenous TGs</strong>. So,<strong> blood VLDL</strong> level is <strong>raised.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Chylomicrons:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carry <strong>TAG </strong>from<strong> gut</strong> to <strong>muscle and adipose tissue</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: HDL:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carry<strong> cholesterol</strong> from <strong>peripheral tissues to liver</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: LDL:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carry<strong> cholesterol </strong>from <strong>liver to peripheral tissues</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>fat-free, high-carbohydrate diet</strong> can lead to <strong>increased synthesis of VLDL</strong> (Very Low-Density Lipoprotein) in the<strong> liver.</strong> <strong>VLDL</strong> is responsible for <strong>transporting endogenously synthesized triglycerides</strong>, which the<strong> body produces</strong> from <strong>excess carbohydrates,</strong> to <strong>adipose tissue</strong> for <strong>storage</strong>. This could contribute to <strong>ongoing obesity </strong>despite the <strong>absence of dietary fat.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 255-257.</span></strong></span></span></p>",
      "correct_choice_id": 36058,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9048,
      "choices": [
        {
          "id": 36159,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicrons</span></span></span></p>"
        },
        {
          "id": 36160,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></span></span></p>"
        },
        {
          "id": 36161,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL</span></span></span></p>"
        },
        {
          "id": 36162,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with coronary artery disease (CAD), currently undergoing treatment, is advised to implement lifestyle modifications and monitor his lipid profile quarterly. Among the lipoproteins evaluated, which one is characterized by the lowest lipid-to-protein ratio?</span></span></span></p>",
      "unique_key": "Q2490427",
      "question_audio": null,
      "question_video": null,
      "map_id": 30306,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> HDL</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>High-density lipoprotein (HDL) </strong>is known for having the <strong>highest protein </strong>content relative to its <strong>lipid content </strong>among the <strong>various lipoproteins, </strong>resulting in the <strong>lowest lipid-to-protein ratio</strong>. This <strong>high protein </strong>content contributes to <strong>HDL&#39;s </strong>denser nature compared to other lipoproteins and its role in <strong>reverse cholesterol transport</strong>, where it <strong>facilitates </strong>the removal of <strong>excess cholesterol from cells </strong>and <strong>atheromatous plaques </strong>in the <strong>arteries</strong>, transporting it back to the <strong>liver for excretion or recycling</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Chylomicrons</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are the <strong>largest lipoproteins </strong>with the <strong>highest lipid content, </strong>primarily <strong>triglycerides</strong>, thus having a <strong>high lipid-to-protein ratio.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: VLDL (Very Low-Density Lipoprotein)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: VLDL particles are <strong>rich in triglycerides </strong>and have a <strong>higher lipid-to-protein ratio </strong>compared to <strong>HDL </strong>but<strong> lower than chylomicrons.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: LDL (Low-Density Lipoprotein)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: LDL carries mostly<strong> cholesterol </strong>and has a <strong>lower lipid-to-protein ratio </strong>than <strong>VLDL </strong>and <strong>chylomicrons but higher than HDL</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/screenshot-2024-04-18-182641.png\" style=\"height:410px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among<strong> different HDL particles</strong>, <strong>percentage of lipids </strong>seen will be:&nbsp;&nbsp; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL<sub>1</sub>&nbsp;: 65%</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL2&nbsp; : 67%</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL3&nbsp; : 43%</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pre&beta;-HDL : 30</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 478-479, 484.</span></strong></span></span></p>",
      "correct_choice_id": 36161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9036,
      "choices": [
        {
          "id": 36111,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">245 mg/dl</span></span></span></p>"
        },
        {
          "id": 36112,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">135 mg/dl</span></span></span></p>"
        },
        {
          "id": 36113,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">85 mg/dl</span></span></span></p>"
        },
        {
          "id": 36114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">45 mg/dl</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman undergoes routine health screening, including a lipid profile, while fasting. Her results show a total cholesterol of 300 mg/dL, HDL cholesterol of 25 mg/dL, and triglycerides of 150 mg/dL. Utilizing the Friedewald equation to assess her cardiovascular risk, what is the LDL cholesterol level in this patient?</span></span></span></p>",
      "unique_key": "Q2855174",
      "question_audio": null,
      "question_video": null,
      "map_id": 30301,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">245 mg/dl</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>total blood cholesterol</strong> in the <strong>fasting state </strong>is <strong>equal</strong> to the <strong>sum </strong>of the <strong>cholesterol in LDL + cholesterol in HDL +</strong> <strong>cholesterol in VLDLs. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This<strong> last term </strong>is calculated by <strong>dividing the triacylglycerol value by 5 </strong>because<strong> cholesterol </strong>accounts for about <strong>1/5 </strong>of the <strong>volume of VLDL in fasted blood</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">300 = LDL cholesterol + 25+150/5</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL cholesterol = 300-55= 245 mg/dl.</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> Friedewald equation</strong>, used to estimate the <strong>level of LDL cholesterol</strong>, is<strong> LDL = Total Cholesterol - HDL - (Triglycerides / 5).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan, 9/e: p241, 242, Lippincott 7/e: p 244</span></strong></span></span></p>",
      "correct_choice_id": 36111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9040,
      "choices": [
        {
          "id": 36127,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APOE3&nbsp; </span></span></span></p>"
        },
        {
          "id": 36128,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APOE1 </span></span></span></p>"
        },
        {
          "id": 36129,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APOE4 </span></span></span></p>"
        },
        {
          "id": 36130,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APOE2</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old man presents with a two-year history of gradually declining cognitive function. PET imaging reveals widespread amyloid deposition, notably in the striatum. Considering the role of apolipoproteins in Alzheimer&#39;s disease pathology, which apolipoprotein variant is most closely associated with this condition?</span></span></span></p>",
      "unique_key": "Q4112074",
      "question_audio": null,
      "question_video": null,
      "map_id": 30303,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">APOE4 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><u><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial AD and Apo-E4 gene:</span></strong></u> <span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is an <strong>association between patients </strong>possessing the <strong>apo E4 allele </strong>and the<strong> incidence</strong> of<strong> Alzheimer disease. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apparently,<strong> apo E4 binds </strong>more <strong>avidly to &beta;-amyloid</strong> found in<strong> neuritic plaques. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Genes</strong> identified with <strong>AD </strong>are that <strong>coding for APP, presenilin-1 (chromosome 14), presenilin-2 (chromosome 1) or AD3</strong> <strong>(chromosome 14) or AD4 (chromosome 1), and Apo-E4 gene (chromosome 19). </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presence of Apo-E4 gene</strong> is the major <strong>risk factor for AD. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: APOE3</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is the <strong>most common allele of APOE</strong> and is considered <strong>neutral </strong>in terms of<strong> Alzheimer&#39;s risk.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: APOE1</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is<strong> not </strong>a commonly <strong>recognized allele </strong>in the context of <strong>Alzheimer&#39;s disease risk.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: APOE2</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This <strong>allele</strong> is considered to have a<strong> protective effect against Alzheimer&#39;s disease, </strong>associated with a <strong>lower risk </strong>of <strong>developing the condition.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>APOE4 </strong>is a <strong>genetic risk factor </strong>for <strong>Alzheimer&#39;s disease, </strong>associated with <strong>increased amyloid deposition</strong> in the<strong> brain</strong> and an <strong>elevated</strong> <strong>risk </strong>of developing the <strong>disease</strong>, particularly at an <strong>earlier age.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 46, 275.</span></strong></span></span></p>",
      "correct_choice_id": 36129,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9046,
      "choices": [
        {
          "id": 36151,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated LDL</span></span></span></p>"
        },
        {
          "id": 36152,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated HDL</span></span></span></p>"
        },
        {
          "id": 36153,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated lipoprotein lipase </span></span></span></p>"
        },
        {
          "id": 36154,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated chylomicrons</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old man with a sedentary lifestyle presents with abdominal pain. An ultrasound reveals hepatomegaly, and his lipid profile, characterized by a creamy layer over clear plasma 24 hours after collection, indicates elevated triglycerides and cholesterol levels. He is diagnosed with Type I hyperlipoproteinemia. Which of the following is a hallmark feature of this condition?</span></span></span></p>",
      "unique_key": "Q5674627",
      "question_audio": null,
      "question_video": null,
      "map_id": 30305,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated chylomicrons</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperlipoproteinemia I/Familial lipoprotein lipase deficiency (type I)&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>autosomal recessive condition </strong>presents with <strong>fasting chylomicronemia and Hypertriacylglycerolemia </strong>due to <strong>deficiency </strong>of<strong> LPL or abnormal LPL or apo C-ll deficiency</strong> causing <strong>inactive LPL</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Slow clearance </strong>of <strong>chylomicrons and VLDL </strong>with<strong> low levels of LDL and HDL</strong> are noted.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F:<strong> Eruptive xanthoma</strong>;<strong> hepatomegaly; Pain abdomen</strong>, manifests in <strong>young age</strong> with<strong> less risk</strong> of<strong> coronary disease.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A<strong> chylomicron</strong> band in <strong>fasting plasma </strong>is the characteristic finding of the disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Elevated LDL:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seen in<strong> type IIA and IIB </strong>and <strong>low levels </strong>in <strong>type I Hyperlipoproteinemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Elevated HDL:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low levels of HDL </strong>in <strong>type I </strong>due to<strong> slow clearance</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Elevated lipoprotein lipase:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>type I Hyperlipoproteinemia, lipoprotein lipase </strong>is <strong>deficient </strong>and <strong>not elevated </strong>as given in the option.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify<strong> Type I hyperlipoproteinemia </strong>by the presence of <strong>elevated chylomicrons</strong>, leading to <strong>high plasma triglyceride levels </strong>and the characteristic appearance of a <strong>lipid profile sample </strong>after<strong> standing</strong>, <strong>indicative </strong>of this condition&#39;s impact on <strong>lipid metabolism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 275.</span></strong></span></span></p>",
      "correct_choice_id": 36154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9050,
      "choices": [
        {
          "id": 36167,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xanthelasma palpebrarum</span></span></span></p>"
        },
        {
          "id": 36168,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xanthoma</span></span></span></p>"
        },
        {
          "id": 36169,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arcus senilis</span></span></span></p>"
        },
        {
          "id": 36170,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tendinous xanthoma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old woman reports having yellowish, soft lesions at the inner corners of the upper eyelids on both eyes for the past three years. Recently, she has noticed an increase in their size. Based on the described location and appearance of the lesions, what is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/7_4tAV0dx.jpg\" style=\"height:183px; width:270px\" /></span></span></span></p>",
      "unique_key": "Q5635507",
      "question_audio": null,
      "question_video": null,
      "map_id": 30307,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xanthelasma palpebrarum</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnosis of the patient is <strong>Familial hypercholesterolemia.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this there is defect is in <strong>LDL receptor or mutation </strong>in the ligand region of <strong>apo B100 </strong>&rarr; so, <strong>LDL </strong>is <strong>not cleared </strong>from the<strong> </strong><strong>blood deposition of lipids </strong>in <strong>subcutaneous tissue </strong>&rarr; leads to <strong>xanthomas</strong>, seen over <strong>tendons </strong>known as <strong>Tendinous xanthoma</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xanthelasma are lipid deposits under the periorbital skin.</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Xanthoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While xanthomas are also<strong> lipid deposits </strong>in the <strong>skin</strong>, they can <strong>occur </strong>in various<strong> parts of the body</strong>, <strong>not </strong>specifically on the <strong>eyelids</strong>. <strong>Xanthelasma </strong>is a <strong>type of xanthoma </strong>that specifically occurs on the <strong>eyelids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Arcus senilis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a <strong>gray or white arc </strong>visible <strong>above and below</strong> the outer part of the <strong>cornea, not </strong>on the <strong>eyelids</strong>, and it&#39;s typically associated with <strong>aging or high cholesterol.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Tendinous xanthoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are <strong>lipid deposits </strong>found in <strong>tendons</strong>, particularly the <strong>Achilles tendon</strong>, <strong>not </strong>on the <strong>eyelids</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xanthelasma palpebrarum </strong>is <strong>soft, yellowish plaques </strong>on the eyelids, indicative of<strong> lipid deposition in the skin</strong>, which may suggest underlying <strong>hyperlipidemia </strong>but can also occur in individuals with <strong>normal lipid profiles.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: P245, 246.</span></strong></span></span></p>",
      "correct_choice_id": 36167,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9054,
      "choices": [
        {
          "id": 36183,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL</span></span></span></p>"
        },
        {
          "id": 36184,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicron</span></span></span></p>"
        },
        {
          "id": 36185,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL</span></span></span></p>"
        },
        {
          "id": 36186,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which human plasma lipoprotein has the highest percentage of triacylglycerol (TAG) by weight?</span></span></span></p>",
      "unique_key": "Q4844476",
      "question_audio": null,
      "question_video": null,
      "map_id": 30309,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chylomicron</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chylomicrons </strong>are the <strong>lipoprotein particles </strong>that contain the <strong>highest </strong>percentage of<strong> triacylglycerol (TAG) </strong>by weight. They are responsible for <strong>transporting dietary lipids</strong>, predominantly <strong>triglycerides</strong>, from the<strong> intestines to other parts </strong>of the <strong>body </strong>for <strong>metabolism or storage</strong>. Due to their <strong>high TAG content</strong>, <strong>chylomicrons </strong>are the <strong>least dense </strong>of the <strong>lipoproteins</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: VLDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Very Low-Density Lipoproteins </strong>(VLDL) carry <strong>endogenously </strong>synthesized <strong>triglycerides </strong>from the <strong>liver to peripheral tissues </strong>but have a <strong>lower </strong>percentage of<strong> triglycerides </strong>compared <strong>to chylomicrons</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: HDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> High-Density Lipoproteins </strong>(HDL) are involved in <strong>reverse cholesterol </strong>transport and contain the <strong>least </strong>amount of <strong>triglycerides </strong>among the options listed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: LDL</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Low-Density Lipoproteins </strong>(LDL) primarily carry <strong>cholesterol </strong>and have a <strong>lower percentage of triglycerides </strong>compared to <strong>VLDL and chylomicrons.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HDL &ndash;<strong> High protein , Phospholipid</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LDL &ndash; <strong>High CHL , CHL Esters</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CM- <strong>High TAG (80%)</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VLDL -<strong> TAG (50%) </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/ed, pg 254</span></strong></span></span></p>",
      "correct_choice_id": 36184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9055,
      "choices": [
        {
          "id": 36187,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Very low density lipoproteins (VLDLs)</span></span></span></p>"
        },
        {
          "id": 36188,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low-density lipoproteins (LDLs)</span></span></span></p>"
        },
        {
          "id": 36189,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High-density lipoproteins (HDLs)</span></span></span></p>"
        },
        {
          "id": 36190,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which lipoprotein is predominantly involved in delivering cholesterol to the tissues?</span></span></span></p>",
      "unique_key": "Q4183207",
      "question_audio": null,
      "question_video": null,
      "map_id": 30310,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low-density lipoproteins (LDLs)&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> uptake of exogenous cholesterol </strong>by <strong>cells </strong>results in a marked suppression of <strong>endogenous cholesterol synthesis</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low-density human lipoprotein not </strong>only contains the greatest ratio of <strong>bound cholesterol to protein </strong>but also has the <strong>greatest potency </strong>in<strong> suppressing endogenous cholesterogenesis. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>LDLs </strong>normally suppress <strong>cholesterol synthesis </strong>by binding to a <strong>specific membrane receptor </strong>that mediates <strong>inhibition </strong>of <strong>hydroxymethylglutaryl (HMG) coenzyme A reductase.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Transport of TAG </strong>from <strong>liver to muscle and adipose tissue</strong>. <strong>Cholesterol</strong> composition <strong>20 %</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Transports Cholesterol </strong>from <strong>peripheral tissues to liver</strong>.<strong> Cholesterol</strong> <strong>10-30%</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Transports FFA </strong>from <strong>adipose Tissue to muscle and liver</strong>. Free fatty acids are<strong> seen in circulation</strong>, <strong>weakly bound to albumin</strong>. <strong>Cholesterol 0%</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low-density lipoproteins (LDLs) </strong>are recognized as the primary carriers of <strong>cholesterol in the bloodstream, delivering cholesterol </strong>to various tissues for use in <strong>cell membranes and other functions. LDLs </strong>bind to <strong>specific LDL receptors </strong>on cell surfaces, <strong>facilitating </strong>the <strong>uptake </strong>of <strong>cholesterol into cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/ed: p225.</span></strong></span></span></p>",
      "correct_choice_id": 36188,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9058,
      "choices": [
        {
          "id": 36199,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LPL deficiency </span></span></span></p>"
        },
        {
          "id": 36200,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tangier disease</span></span></span></p>"
        },
        {
          "id": 36201,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial hypercholesterolemia</span></span></span></p>"
        },
        {
          "id": 36202,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abetalipoproteinemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A clinician is treating a patient presenting with tendon xanthomas, elevated LDL levels, and high serum cholesterol. The patient has been prescribed lovastatin, a cholesterol-lowering medication. Based on these clinical features, what is the most likely diagnosis? </span></span></span></p>",
      "unique_key": "Q1076854",
      "question_audio": null,
      "question_video": null,
      "map_id": 30312,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial hypercholesterolemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical &amp; lab features are suggestive of <strong>Familial hypercholesterolemia</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>defect </strong>is in the<strong> </strong><strong>gene for the LDL receptor or mutation </strong>in the ligand region of <strong>apo B100 </strong>&rarr; so <strong>LDL is not cleared </strong>from the<strong> </strong><strong>blood</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>deposition of lipids </strong>in <strong>subcutaneous tissue </strong>leads to <strong>xanthomas</strong>, seen <strong>over tendons </strong>known as <strong>Tendinous xanthoma</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xanthelasma </strong>are <strong>lipid </strong>deposits under the <strong>periorbital skin.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deposits of <strong>lipids in cornea </strong>lead to<strong> corneal arcus</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: LPL deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lipoprotein lipase (LPL) deficiency leads to<strong> elevated chylomicrons</strong>, causing <strong>high triglycerides </strong>but <strong>not </strong>typically resulting in <strong>high LDL or tendon xanthomas</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Tangier disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Characterized by <strong>very low levels of high-density lipoprotein (HDL) </strong>and can lead to the <strong>deposition </strong>of <strong>cholesterol </strong>in tissues, but it <strong>does not </strong>typically present with <strong>elevated LDL levels </strong>and<strong> tendon xanthomas.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Abetalipoproteinemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A <strong>rare </strong>condition characterized by the <strong>absence of apolipoprotein B</strong>-containing <strong>lipoproteins</strong>, leading to <strong>fat malabsorption </strong>and <strong>neurological </strong>symptoms<strong>, not high LDL or cholesterol levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation and appropriate treatment for<strong> familial hypercholesterolemia, </strong>includes <strong>high LDL cholesterol, tendon xanthomas</strong>, and the<strong> use of statin </strong>medications like <strong>lovastatin to lower cholesterol levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p245, 246.</span></strong></span></span></p>",
      "correct_choice_id": 36201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9060,
      "choices": [
        {
          "id": 36207,
          "text": "<p><span style=\"font-size:12.0pt;\">Broad beta disease</span></p>"
        },
        {
          "id": 36208,
          "text": "<p><span style=\"font-size:12.0pt;\">Abetalipoproteinemia</span></p>"
        },
        {
          "id": 36209,
          "text": "<p><span style=\"font-size:12.0pt;\">Familial Hyper Chylomicronemia</span></p>"
        },
        {
          "id": 36210,
          "text": "<p><span style=\"font-size:12.0pt;\">Familial Hypercholesterolemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 50-year-old man with abdominal pain is found to have hepatomegaly via ultrasound. On examination, he exhibits skin findings as shown in the image, with a blood sample that appears creamy and shows elevated triglycerides levels. Based on the clinical presentation and laboratory findings, what is the most likely diagnosis?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:242/128;width:57.43%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/11_XE3FVIl.jpg\" alt=\"\" width=\"242\" height=\"128\"></span></p>",
      "unique_key": "Q3354613",
      "question_audio": null,
      "question_video": null,
      "map_id": 30313,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Familial Hyper Chylomicronemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Familial&nbsp;</strong>Hyper<strong> Chylomicronemia Syndrome</strong> (also known as <strong>Type I Hyperlipoproteinemia</strong>) is a <strong>rare autosomal recessive disorder</strong> caused by <strong>lipoprotein lipase (LPL) deficiency</strong> or dysfunction, or by <strong>apo C-II deficiency</strong>, which is a necessary cofactor for LPL activation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key clinical features:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Eruptive xanthomas</strong> (small, yellow papules, especially on the buttocks or extensor surfaces)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hepatomegaly</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Recurrent abdominal pain</strong> (may be related to pancreatitis)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Milky or creamy plasma</strong> appearance</span></li><li><span style=\"font-size:12.0pt;\"><strong>Very high serum triglyceride levels</strong>, often &gt;1000 mg/dL</span></li></ul><p><span style=\"font-size:12.0pt;\">Although this condition typically presents in <strong>childhood or adolescence</strong>, adult presentations can occur, especially if the diagnosis is delayed or partial enzyme activity exists.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A: Broad Beta Disease (Type III Hyperlipoproteinemia)</strong> – Associated with <strong>palmar xanthomas</strong> and elevated <strong>remnants</strong>. Presents with <strong>increased cardiovascular risk</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B: Abetalipoproteinemia</strong> – Features <strong>very low serum triglycerides and cholesterol</strong>, <strong>acanthocytosis</strong>, <strong>fat malabsorption</strong>, and <strong>retinal degeneration</strong>. Plasma is not creamy.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D: Familial Hypercholesterolemia (Type IIa)</strong> – Caused by <strong>LDL receptor mutations</strong>, presents with <strong>tendinous xanthomas</strong>, <strong>corneal arcus</strong>, and <strong>very high LDL cholesterol</strong> levels. Triglycerides are usually normal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Recognize <strong>Familial Chylomicronemia Syndrome</strong> by:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Eruptive xanthomas</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Creamy plasma with markedly elevated triglycerides</strong></span></li></ul><p><span style=\"font-size:12.0pt;\">It reflects a defect in <strong>chylomicron clearance</strong>, due to <strong>LPL enzyme deficiency or its apo C-II cofactor</strong>, resulting in accumulation of triglyceride-rich lipoproteins in plasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ref: Harper 30/e: p 275.</span></p>",
      "correct_choice_id": 36209,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9061,
      "choices": [
        {
          "id": 36211,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">130</span></p>"
        },
        {
          "id": 36212,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">100</span></p>"
        },
        {
          "id": 36213,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">75</span></p>"
        },
        {
          "id": 36214,
          "text": "<p><span style=\"font-size:12pt;\">50</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A physician is advising a patient on target LDL cholesterol levels for optimal cardiovascular health. what is the recommended upper limit for LDL cholesterol in mg/dl?</span></p>",
      "unique_key": "Q9059763",
      "question_audio": null,
      "question_video": null,
      "map_id": 30314,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 100</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For <strong>optimal cardiovascular health,</strong> particularly in <strong>primary prevention</strong> (patients without existing cardiovascular disease), the <strong>recommended upper limit for LDL cholesterol is typically ≤100 mg/dL.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key guidelines (such as those from the <strong>American Heart Association</strong> and <strong>NCEP ATP III</strong>) suggest:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>&lt;100 mg/dL:</strong> Optimal LDL level</span></li><li><span style=\"font-size:12.0pt;\"><strong>100–129 mg/dL:</strong> Near or above optimal</span></li><li><span style=\"font-size:12.0pt;\"><strong>130–159 mg/dL:</strong> Borderline high</span></li><li><span style=\"font-size:12.0pt;\"><strong>160–189 mg/dL:</strong> High</span></li><li><span style=\"font-size:12.0pt;\"><strong>≥190 mg/dL:</strong> Very high</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. 130 mg/dL:</strong> This is considered <strong>borderline high</strong> for LDL, not the optimal upper limit.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. 75 mg/dL:</strong> it’s <strong>below the general upper limit</strong> for most patients.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. 50 mg/dL:</strong> Not a standard upper limit; <strong>too low</strong> for general recommendation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Understand that <strong>&lt;100 mg/dL</strong> is the widely recommended <strong>upper limit</strong> for LDL cholesterol in general cardiovascular prevention.</span></li></ul>",
      "correct_choice_id": 36212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9062,
      "choices": [
        {
          "id": 36215,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atherosclerosis</span></span></span></p>"
        },
        {
          "id": 36216,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholestasis</span></span></span></p>"
        },
        {
          "id": 36217,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MI</span></span></span></p>"
        },
        {
          "id": 36218,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatitis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a clinical discussion on the diagnostic significance of various lipoproteins, a medical instructor inquires about the clinical condition associated with elevated levels of Lipoprotein X. Which condition is indicated by the presence of Lipoprotein X?</span></span></span></p>",
      "unique_key": "Q8656979",
      "question_audio": null,
      "question_video": null,
      "map_id": 30315,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholestasis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>cholestasis</strong>,<strong> free cholesterol </strong>combines with <strong>phospholipids </strong>and secreted into<strong> plasma </strong>as a constituent of a <strong>lamellar</strong> <strong>particle called LP- X</strong> &rarr; gets <strong>deposited in skinfolds</strong> &rarr; <strong>producing lesions</strong> resembling those in <strong>FDBL. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Plantar and eruptive xanthomas</strong> are also<strong> seen </strong>in<strong> patients </strong>with<strong> cholestasis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Atherosclerosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While atherosclerosis involves <strong>lipid accumulation,</strong> <strong>Lipoprotein X</strong> is <strong>not</strong> a <strong>specific </strong>indicator for this condition. Traditional lipoproteins like <strong>LDL and HDL</strong> are <strong>more</strong> closely related to <strong>atherosclerotic risk.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Myocardial Infarction (MI)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Lipoprotein X</strong> is <strong>not</strong> a biomarker for <strong>MI</strong>.<strong> Cardiac troponins</strong> and other markers like <strong>CK-MB </strong>are used to diagnose <strong>myocardial infarction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Hepatitis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hepatitis refers to <strong>inflammation of the liver</strong>, which can be <strong>due to viral infections</strong> or other causes. <strong>Elevated</strong> <strong>Lipoprotein X</strong> is<strong> not</strong> a specific marker for<strong> hepatitis</strong>, although<strong> liver function tests </strong>may <strong>show abnormalities</strong> in this condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipoprotein X</strong> is an <strong>abnormal lipoprotein</strong> that is often present in the<strong> plasma of patients with cholestasis,</strong> a condition characterized by<strong> impaired bile flow.</strong> The <strong>accumulation of lipids </strong>that are<strong> normally excreted in bile</strong> leads to the formation of this <strong>atypical</strong> <strong>lipoprotein</strong>. Its <strong>detection </strong>can serve as an<strong> indicator of cholestatic liver disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9 /ed: p 229.</span></strong></span></span></p>",
      "correct_choice_id": 36216,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}